Artificial aptamer that inhibits interleukin-23/interleukin-23 receptor interaction discovered via SELEX
Artificial aptamer that inhibits interleukin-23/interleukin-23 receptor interaction discovered via SELEX
复制标题
通过 SELEX 发现抑制白细胞介素 23/白细胞介素 23 受体相互作用的人工适体
DOI:
10.1016/j.bbrc.2022.05.012
复制
发表时间:
2022
影响因子:
3.1
通讯作者:
Kawakami Takashi
中科院分区:
文献类型:
--
作者:
Takamori Yukio;Ando Takehiro;Sato Masashi;Vedi Santhana;Fuji Daisuke;Yokoyama Takumi;Tsukamoto Keita;Yamamoto Mizuki;Kawakami Takashi
Interaction between the pro-inflammatory cytokine interleukin-23 (IL-23) and IL-23 receptor (IL-23R) is related to the development of inflammatory autoimmune diseases such as psoriasis, inflammatory bowel disease, and Crohn's disease. In this study, we conducted systematic evolution of ligands by exponential enrichment (SELEX) forin vitroselection against human IL-23 and observed RNA sequence enrichment in the final SELEX round. IL-23-pull-down assay by chemiluminescence detection and fluorescence imaging demonstrated that SELEX-enriched RNA clone bound to IL-23. Quantitative polymerase chain reaction-based pull-down assay using the IL-23 alpha (IL-23A) subunit, a component of the IL-23 heterodimer, indicated that the RNA clone bound to IL-23A, which is favorable for autoimmune disease treatment. We also observed that the novel IL-23-binding RNA aptamer inhibited interaction between IL-23 and IL-23R. Thus, the novel IL-23-binding RNA aptamer can be used for IL-23 studies and has potential to be used for IL-23 diagnosis and IL-23-related inflammatory autoimmune disease treatment.